Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome

…, M Chernick, WK Steagall, CG Glasgow… - American journal of …, 2008 - atsjournals.org
Rationale: Pulmonary nontuberculous mycobacterial (PNTM) disease is increasing, but
predisposing features have been elusive. Objectives: To prospectively determine the morphotype…

Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management

…, AM Taveira-DaSilva, CG Glasgow… - American journal of …, 2016 - atsjournals.org
Background: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that primarily
affects women. The purpose of these guidelines is to provide recommendations for the …

Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement

CG Glasgow, NA Avila, JP Lin, MP Stylianou, J Moss - Chest, 2009 - Elsevier
Background Lymphangioleiomyomatosis (LAM) is a rare multisystem disorder affecting primarily
women of child-bearing age, and characterized by cystic lung destruction, tumors of the …

Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis

CG Glasgow, S El-Chemaly… - European Respiratory …, 2012 - Eur Respiratory Soc
The primary function of the lymphatic system is absorbing and transporting macromolecules
and immune cells to the general circulation, thereby regulating fluid, nutrient absorption and …

Lymphatic involvement in lymphangioleiomyomatosis

CG Glasgow, AM Taveira‐DaSilva… - Annals of the New …, 2008 - Wiley Online Library
Lymphangioleiomyomatosis (LAM) is a rare, multisystem disease affecting primarily
premenopausal women. The disease is characterized by cystic lung disease, at times leading to …

Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis

WK Steagall, CG Glasgow… - … of Physiology-Lung …, 2007 - journals.physiology.org
Lymphangioleiomyomatosis, a multisystem disease affecting women, is characterized by
proliferation of abnormal smooth muscle-like cells in the lungs, leading to cystic destruction of …

[HTML][HTML] Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies

CG Glasgow, WK Steagall, A Taveira-DaSilva… - Respiratory …, 2010 - Elsevier
Glasgow a d , Wendy K. Steagall a e , Angelo Taveira-DaSilva a f , Gustavo Pacheco-Rodriguez
a g , Xiong Cai a h , Souheil El-Chemaly a i , Marsha Moses b j , Thomas Darling c k , …

ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis

…, M Stylianou, V Hoffmann, MJ Lizak, CG Glasgow… - Cancer research, 2011 - AACR
Protein ADP-ribosylation is a reversible posttranslational modification of uncertain significance
in cancer. In this study, we evaluated the consequences for cancer susceptibility in the …

CA-125 in disease progression and treatment of lymphangioleiomyomatosis

CG Glasgow, G Pacheco-Rodriguez, WK Steagall… - Chest, 2018 - Elsevier
Glasgow BA a , Gustavo Pacheco-Rodriguez PhD a , Wendy K. Steagall PhD a , Mary E. …
JM, CG, G. PR., and WS provided the conceptual framework and drafted the manuscript. CG

Involvement of lymphatics in lymphangioleiomyomatosis

CG Glasgow, A Taveira–DaSilva… - … research and biology, 2009 - liebertpub.com
Lymphangioleiomyomatosis (LAM), a rare multisystem disease, occurs primarily in women,
with cystic destruction of the lungs, abdominal tumors, and involvement of the axial …